Drug recall D-0807-2026
Product
Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24.
Reason for recall
CGMP Deviations
Lots and codes
Lot # NC188692, Exp Date: 11/22/2027.
Recall details
- Recalling firm
- Baxter Healthcare Corporation, Deerfield, IL
- Quantity
- N/A
- Distribution
- US Nationwide; Puerto Rico; and Chile.
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 6, 2026
Related products
- Daptomycin in Sodium Chloride – drug information
- NDC 0338-0712 Daptomycin in Sodium Chloride · Daptomycin 350 mg/50mL · Baxter Healthcare Corporation
- NDC 0338-0714 Daptomycin in Sodium Chloride · Daptomycin 500 mg/50mL · Baxter Healthcare Corporation
- NDC 0338-0716 Daptomycin in Sodium Chloride · Daptomycin 700 mg/100mL · Baxter Healthcare Corporation
- NDC 0338-0718 Daptomycin in Sodium Chloride · Daptomycin 1000 mg/100mL · Baxter Healthcare Corporation